SPY332.80-2.77 -0.83%
DIA277.19-0.95 -0.34%
IXIC10,782.82-185.53 -1.69%

Vertex Pharmaceuticals Q2 EPS $2.61 Beats $2.07 Estimate, Sales $1.52B Beat $1.39B Estimate

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $2.61 per share which beat the analyst consensus estimate of $2.07 by 26.09 percent. This is a 107.14 percent increase over earnings of $1.26 per share

Benzinga · -
Vertex Pharmaceuticals (NASDAQ: VRTX) reported quarterly earnings of $2.61 per share which beat the analyst consensus estimate of $2.07 by 26.09 percent. This is a 107.14 percent increase over earnings of $1.26 per share from the same period last year. The company reported quarterly sales of $1.52 billion which beat the analyst consensus estimate of $1.39 billion by 9.64 percent. This is a 61.91 percent increase over sales of $941.28 million the same period last year.